Single daily oral dose of gemfibrozil reduces postprandial hyperlipidemia in hyperlipidemic patients

Authors: Descamps O.; Hondekijn J.-C.; Godrie T.; Desager J.-P.; Heller F.R.1

Source: Current Therapeutic Research, Volume 59, Number 8, August 1998 , pp. 545-555(11)

Publisher: Elsevier

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: gemfibrozil; hyperlipidemia; postprandial hyperlipidemia; lipoprotein lipase; hepatic lipase

Language: English

Document Type: Research article

DOI: 10.1016/S0011-393X(98)85094-7

Affiliations: 1: aTumor Metabolism Study Group, Hopital de Jolimont, Haine Saint Paul, , Belgium

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A